Endo Pharmaceuticals Drives Growth in Pain Management with Acquisition of Penwest

By Heather Cartwright

Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)

Published: 21 Sep-2010

DOI: 10.3833/pdr.v2010.i7.1374     ISSN: 1756-7874

Section: Mergers & Acquisitions



Endo Pharmaceuticals has acquired its long-term partner Penwest Pharmaceuticals, in a deal valued at US$168 M that will enable it to drive growth in pain management...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details